Pharmaceutical

Cognition Corporation Launches Compass MED: A Revolutionary Solution to Simplify and Accelerate Medical Device Development

As medical devices become increasingly more complex, the need to enhance development efficiency, quality by design, integrated risk management, and…

4 months ago

DeepIntent and Everyday Health Group Partner to Offer Exclusive Access to Premium Health Segments and Advanced Targeting

The partnership enhances DeepIntent's platform with premium, first-look media offerings and provides Everyday Health Group with an advanced DSP platform…

4 months ago

Slope Launches Tech-Enabled Services to Bolster Biospecimen Lifecycle Management in Clinical Trials

New tech-enabled services empower pharmaceutical companies to optimize biospecimen operations and data management, transforming sample data into actionable insights RICHMOND,…

4 months ago

IntegriChain and Federal Compliance Solutions Experts to Speak on the Intricacies Inflation Reduction Act at MDRP Summit

PHILADELPHIA, Sept. 10, 2024 /PRNewswire/ -- IntegriChain, the leading provider of pharma revenue optimization technology and insights for the pharmaceutical industry,…

4 months ago

Purisys Activates Drug Master File for Nalmefene, Introducing New Solution for Acute Opioid Overdose Treatment

Athens, Georgia--(Newsfile Corp. - September 10, 2024) - Purisys LLC, a leading supplier of active pharmaceutical ingredients (APIs), contract development…

4 months ago

Jones Healthcare Group Partners with GDK Marketing to Strengthen Presence in Quebec’s Pharmacy Market

New Partnership Enhances Jones Healthcare Group's Reach in Quebec with Local Expertise and French-Language SupportLondon, Ontario--(Newsfile Corp. - September 10,…

4 months ago

Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma

Soquelitinib is a potential first-in-class ITK inhibitor with broad potential in cancer and immune diseases There are currently no fully…

4 months ago

Danam Health, Inc. Announces Acquisition of Wellgistics, LLC

Tampa, FL, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Danam Health, Inc. (“Danam”) today announced that it completed its acquisition of…

4 months ago

New Secondary Analysis of Phase 3 Data Demonstrates Sotagliflozin Improves Time-In-Range (TIR) and Several Parameters of Glucose Control and Variability in Basal Insulin-Treated Type 2 Diabetes

Study results aligned with positive clinical trial outcomes for type 1 diabetes treatment with sotagliflozin   TIR measures approach target set…

4 months ago

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are

AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The latest report from the Access to Medicine Foundation takes a first-ever look…

4 months ago